Skip to content

Clinical trials

Terminated Phase 3 Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Status: Terminated Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20042
20053
20065
20074
20085
20093
20101
20111
20121
20141
20152
20162
20171
20182
20192
20205
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ferring Pharmaceuticals3
Ipsen3
M.D. Anderson Cancer Center3
Cell Genesys2
European Organisation for Research and Treatment of Cancer - EORTC2
Merck Sharp & Dohme LLC2
Sanofi2
Agennix1
AstraZeneca1
Bracco Diagnostics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms51
Neoplasm Metastasis4
Neoplasms4
Erectile Dysfunction2
Brain Neoplasms1
Breast Neoplasms1
Hot Flashes1
Lung Neoplasms1
Metabolic Syndrome1
Osteoporosis1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.